Previous close | 4.7000 |
Open | 4.7000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 640.00 |
Expiry date | 2024-09-20 |
Day's range | 4.7000 - 4.7000 |
Contract range | N/A |
Volume | |
Open interest | 92 |
WALTHAM, Mass., June 20, 2024--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the "Buyer"), has extended the expiration time of the offering period of its previously announced tender offer (the "Offer") to acquire all of the outstanding common shares ("Shares") and all of the outstanding American Depositary Shares, each representing one Share ("ADSs"), of Olink Holding AB (publ) (
Key Insights The projected fair value for Thermo Fisher Scientific is US$423 based on 2 Stage Free Cash Flow to Equity...
Thermo Fisher's (TMO) first-of-its-kind innovation for CO2 incubators supports emerging automated cell therapy production processes.